PageSourceSearch

https://medinice.pl/component---src-pages-products-coolcryo-tsx-305c37a7bab1d08ffd9f.js

js medinice.pl collected 2026-10-05 21:44:11 UTC 39,574 bytes, 2 lines download raw bytes

1"use strict";(self.webpackChunkmedi_website=self.webpackChunkmedi_website||[]).push([[6060],{3268:function(e,a,t){t.r(a),t.d(a,{default:function(){return d}});var l=t(96540),r=t(47444),n=t(46500),o=t(24794),i=t(33360),c=t(32532),s=t(3702),m=t.p+"static/CoolCryoposterISMICS2025desktop-94704e260caaba96e431482adfe8f5e0.jpg",g=t.p+"static/CoolCryoposterISMICS2025mobile-7276baebfbaf66b9b21cc906796918d7.jpg";var d=()=>{const e=(0,r.vc)(n.y$),{0:a,1:d}=(0,l.useState)(!1);return l.createElement(l.Fragment,null,l.createElement("section",{className:"flex w-full mt-0 lg:mt-20 items-center h-[50vh] lg:h-full"},l.createElement(c.S,{src:"../../images/productCoolCryoHeroPhoto.jpg",alt:"CoolCryo photo",className:"lg:bg-center flex w-auto lg:w-full h-full lg:min-w-[200px] object-cover lg:min-h-[280px] lg:h-[640px] max-h-[100vh] lg:max-h-[640px] relative min-h-[100%] max-w-full",loading:"lazy",__imageData:t(15627)}),l.createElement(i.H,{className:"left-[50%] -translate-x-[50%] absolute top-[192px] lg:top-[440px] lg:-mt-[20px] w-full !items-start"},l.createElement("div",{className:"flex flex-col gap-6"},l.createElement("h1",{className:"flex flex-col font-semibold text-white leading-[1.4] lg:leading-[1.2] pl-0 lg:pl-20",style:{textShadow:"0 0 10px rgba(0, 0, 0, 0.7)"}},l.createElement("span",{className:"text-3xl lg:text-6xl mb-2 lg:mb-2"},"CoolCryo"),l.createElement("span",{className:"text-2xl lg:text-4xl"},"pl-PL"==e?"Szybka i skuteczna krioablacja":"Quick and Powerful Cryoablation"))))),l.createElement("section",{className:"mt-10 lg:mt-20 mb-10 lg:mb-0 lg:-ml-18"},l.createElement(i.H,null,l.createElement("div",{className:"flex flex-col lg:flex-row gap-6 lg:gap-20"},l.createElement("div",{className:"flex flex-col order-1 lg:order-2 w-full lg:w-1/2"},l.createElement("h2",{className:"text-xl lg:text-2xl font-bold text-black text-start w-full mb-4"},"pl-PL"==e?"System do krioablacji serca":"Cardiac Cryoablation System"),l.createElement("p",{className:"text-base lg:text-xl text-start lg:text-start max-w-[740px] mb-4 pr-0 lg:pr-8"},"pl-PL"===e&&"CoolCryo to system do krioablacji serca wykorzystujący ciekły azot jako medium chłodzące. Ciekły azot jest powszechnie dostępny, szeroko stosowany i należy do najtańszych środków chłodzących, co znacząco obniża koszt zabiegu i zwiększa jego dostępność. Główną zaletą systemu CoolCryo jest podgrzewana, formowalna końcówka, która umożliwia szybkie przeprowadzenie krioablacji, skracając tym samym czas trwania zabiegu.","en-US"===e&&"CoolCryo is a cardiac cryoablation technology that uses liquid nitrogen as the cooling medium. Liquid nitrogen is widely available, commonly used, and one of the most cost-effective cooling agents, which significantly reduces the cost of the procedure and increases its accessibility. One of the key advantages of CoolCryo is its heated, formable tip, which enables fast ablation and thus shortens the duration of the procedure.")),l.createElement("div",{className:"!flex-col !items-start pl-0 lg:-pl-16 w-full lg:w-1/2 order-2 lg:order-1"},l.createElement("iframe",{className:"rounded-lg",width:"100%",height:"300",src:"https://www.youtube.com/embed/IGCefPTv7Bw",title:"CoolCryo teaser",frameBorder:"0",allow:"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share",referrerPolicy:"strict-origin-when-cross-origin",allowFullScreen:!0}))))),l.createElement("section",{className:"w-full flex justify-center items-center pt-10 pb-4 lg:pt-20 lg:pb-12 mt-6 lg:mt-20 mb-0 lg:mb-20 bg-gray-100"},l.createElement(i.H,null,l.createElement("div",{className:"flex flex-col lg:flex-row gap-2 lg:gap-10 pl-0 lg:pl-20 pb-4 lg:pb-0"},l.createElement("h2",{className:"flex lg:hidden text-xl lg:text-3xl font-bold text-black text-start w-full mb-4 mt-0 lg:mt-0"},"pl-PL"==e?"Problem":"The Problem"),l.createElement("div",{className:"flex flex-col lg:w-1/2 order-2 lg:order-1 pr-0 lg:pr-20"},l.createElement("h2",{className:"hidden lg:flex text-xl lg:text-3xl font-bold text-black text-start w-full mb-4 mt-8 lg:mt-0"},"pl-PL"==e?"Problem":"The Problem"),l.createElement("h3",{className:"text-lg lg:text-xl font-bold text-black text-start w-full mb-4 mt-4 lg:mt-0"},"pl-PL"==e?"Migotanie przedsionków to najczęstsze zaburzenie rytmu serca, powodujące nieregularne i często zbyt szybkie bicie przedsionków.":"Atrial fibrillation (AFib) is the most common heart rhythm disorder that causes the upper chambers of the heart to beat irregularly and often rapidly."),l.createElement("p",{className:"text-base lg:text-xl text-start lg:text-start max-w-[740px] mb-4 pr-0 lg:pr-8"},"pl-PL"===e&&l.createElement(l.Fragment,null,"Nieleczone migotanie przedsionków może prowadzić do poważnych powikłań, takich jak udar mózgu, niewydolność serca czy przewlekłe zmęczenie, znacząco obniżając jakość życia. Do typowych problemów związanych z tym schorzeniem należą:"),"en-US"===e&&l.createElement(l.Fragment,null,"Uncontrolled atrial fibrillation can lead to serious complications, including stroke, heart failure, and chronic fatigue—significantly reducing quality of life. Common issues include:")),l.createElement("ul",{className:"flex flex-col text-base lg:text-xl list-disc list-outside max-w-[740px] mb-0 lg:mb-4 pr-0 lg:pr-8 pl-4 lg:pl-6 gap-2 text-[#03466C] font-semibold"},"pl-PL"===e&&l.createElement(l.Fragment,null,l.createElement("li",{className:"pl-2"},"nawet pięciokrotny wzrost ryzyka udaru mózgu"),l.createElement("li",{className:"pl-2"},"objawy takie jak duszność, zawroty głowy czy kołatanie serca"),l.createElement("li",{className:"pl-2"},"inne nietypowe objawy, które często pozostają niewykryte")),"en-US"===e&&l.createElement(l.Fragment,null,l.createElement("li",null,"stroke risk up to 5× higher"),l.createElement("li",null,"breathlessness, dizziness, palpitations"),l.createElement("li",null,"other unusual symptoms that often go unnoticed")))),l.createElement("div",{className:"lg:w-1/2 flex justify-center items-start order-1 lg:order-2 rounded-lg overflow-hidden pl-0 lg:-ml-20"},l.createElement(c.S,{src:"../../images/atrialfibrillation.jpg",alt:"PacePress schema",className:"w-full h-auto rounded-lg shadow-lg max-w-[640px]",__imageData:t(88271)}))))),l.createElement("section",{className:"w-full flex justify-center items-center mt-10 lg:mt-0 mb-0 lg:mb-0"},l.createElement(i.H,null,l.createElement("div",{className:"w-full flex flex-col-reverse lg:flex-row-reverse gap-2 lg:gap-0"},l.createElement("div",{className:"flex flex-col lg:w-1/2"},l.createElement("h2",{className:"text-xl lg:text-2xl font-bold text-black text-start w-full mb-4 mt-8 lg:mt-0"},"pl-PL"==e?"Skuteczność przezskórnej ablacji - kiedy pomaga, a kiedy może nie wystarczyć":"When Catheter Ablation Works — and When It May Not"),l.createElement("ul",{className:"flex flex-col text-base lg:text-xl list-disc list-outside max-w-[740px] mb-0 lg:mb-4 pr-0 lg:pr-8 pl-4 lg:pl-6 gap-4"},"pl-PL"===e&&l.createElement(l.Fragment,null,l.createElement("li",{className:"pl-2"},"Ablacja przezskórna to skuteczne leczenie migotania przedsionków oraz innych arytmii. Usuwa niewielkie obszary tkanki serca odpowiadające za nieprawidłowe sygnały, przywracając prawidłowy rytm i łagodząc objawy."),l.createElement("li",{className:"pl-2"},"Skuteczność zależy od stopnia zaawansowania choroby. W przypadku zaawansowanej lub długotrwałej choroby efekty mogą być mniej trwałe. Czasem potrzebne są kolejne zabiegi jak np. ablacja chirurgiczna.")),"en-US"===e&&l.createElement(l.Fragment,null,l.createElement("li",{className:"pl-2"},"Catheter ablation is an effective treatment for atrial fibrillation (AFib) and other arrhythmias. It targets small areas of heart tissue causing abnormal signals, helping restore normal rhythm and reduce symptoms."),l.createElement("li",{className:"pl-2"},"Its success varies with disease stage. In advanced or long-standing AFib, results may not last. Some patients need extra treatments such as surgical ablation.")))),l.createElement("div",{className:"lg:w-1/2 flex justify-center items-start ml-0 lg:-ml-10"},l.createElement(c.S,{src:"../../images/cardiacablation.jpg",alt:"PacePress schema",className:"w-full h-auto rounded-lg max-w-[520px]",__imageData:t(24663)}))))),l.createElement("section",{className:"w-full flex justify-center items-center pt-6 pb-4 lg:pt-20 lg:pb-20 mt-6 lg:mt-16 mb-0 lg:mb-20 bg-gray-100"},l.createElement(i.H,null,l.createElement("div",{className:"flex flex-col lg:flex-row gap-2 lg:gap-10 pl-0 lg:pl-20"},l.createElement("h3",{className:"flex lg:hidden text-lg lg:text-2xl font-bold text-black text-start w-full mb-4 mt-0 lg:mt-0"},"pl-PL"==e?"Unikalna konstrukcja oraz funkcjonalności":"Unique design and ke
1y features"),l.createElement("div",{className:"flex flex-col lg:w-1/2 order-2 lg:order-1 pr-0 lg:pr-20"},l.createElement("h3",{className:"hidden lg:flex text-lg lg:text-2xl font-bold text-black text-start w-full mb-4 mt-4 lg:mt-0"},"pl-PL"==e?"Unikalna konstrukcja oraz funkcjonalności":"Unique design and key features"),l.createElement("p",{className:"text-base lg:text-xl text-start lg:text-start max-w-[740px] mt-4 lg:mt-0 mb-4 pr-0"},"pl-PL"===e&&l.createElement(l.Fragment,null,"Innowacyjny system krioablacji oparty na ciekłym azocie"),"en-US"===e&&l.createElement(l.Fragment,null,"Innovative liquid nitrogen-based cryoablation system")),l.createElement("p",{className:"text-base lg:text-xl text-start lg:text-start max-w-[740px] mb-4 pr-0 lg:pr-8"},"pl-PL"===e&&l.createElement(l.Fragment,null,"Kształtowana końcówka z aluminium do precyzyjnych oraz szybszych zabiegów"),"en-US"===e&&l.createElement(l.Fragment,null,"Moldable aluminum tip for precise and faster procedures")),l.createElement("p",{className:"text-base lg:text-xl text-start lg:text-start max-w-[740px] mb-4 pr-0 lg:pr-8"},"pl-PL"===e&&l.createElement(l.Fragment,null,"Regulowana głębokość ablacji dzięki ustawieniom czasu i temperatury"),"en-US"===e&&l.createElement(l.Fragment,null,"Adjustable ablation depth via time and temperature settings")),l.createElement("p",{className:"text-base lg:text-base text-start lg:text-start max-w-[740px] mb-4 pr-0 lg:pr-8"},"pl-PL"===e&&l.createElement(l.Fragment,null,"Źródło (3): Oparte na danych eksperymentalnych Medinice uzyskanych w trakcie badań przedklinicznych oraz na danych pochodzących z innych dostępnych źródeł."),"en-US"===e&&l.createElement(l.Fragment,null,"Reference (3): Based on Medinice experimental data during preclinical studies and data from other available sources."))),l.createElement("div",{className:"lg:w-1/2 flex justify-center items-start order-1 lg:order-2 rounded-lg overflow-hidden pl-0 lg:-ml-20"},"pl-PL"===e?l.createElement(c.S,{src:"../../images/CoolCryofreezingGraphsPL.jpg",alt:"Krzywe mrożenia CoolCryo vs konkurencja",className:"w-full h-auto max-w-[640px] rounded-md",__imageData:t(26256)}):l.createElement(c.S,{src:"../../images/CoolCryofreezingGraphsEN.jpg",alt:"Freezing curves CoolCryo vs competition",className:"w-full h-auto max-w-[640px] rounded-md",__imageData:t(85522)}))))),l.createElement("section",{className:"w-full flex justify-center items-center mt-10 lg:mt-0 mb-0 lg:mb-0"},l.createElement(i.H,null,l.createElement("div",{className:"w-full flex flex-col-reverse lg:flex-row-reverse gap-2 lg:gap-0"},l.createElement("div",{className:"flex flex-col lg:w-1/2"},l.createElement("h2",{className:"text-xl lg:text-2xl font-bold text-black text-start w-full mb-4 mt-8 lg:mt-0"},"pl-PL"==e?"Czy jedno mrożenie jest równe innemu mrożeniu?":"Freezing equals freezing?"),l.createElement("ul",{className:"flex flex-col text-base lg:text-xl list-disc list-outside max-w-[740px] mb-0 lg:mb-4 pr-0 lg:pr-8 pl-4 lg:pl-6 gap-4"},"pl-PL"===e&&l.createElement(l.Fragment,null,l.createElement("li",{className:"pl-2"},"Szybkie zamrażanie - cztery razy szybciej niż przy użyciu innych wyrobów medycznych - skuteczniejsza martwica",l.createElement("sup",{className:"text-sm"},"2")),l.createElement("li",{className:"pl-2"},"Liniowe głębokie zamrażanie dzięki najniższej temperaturze kriogenu oraz najwyższej pojemności cieplnej kriogenu, większa objętość zmian",l.createElement("sup",{className:"text-sm"},"1"))),"en-US"===e&&l.createElement(l.Fragment,null,l.createElement("li",{className:"pl-2"},"Quick freezing - four times faster than with other devices - more efficient necrosis",l.createElement("sup",{className:"text-sm"},"2")),l.createElement("li",{className:"pl-2"},"Linear deep freezing due to coldest cryogen temperature and highest cryogen heat capacity, higher volume of lesions",l.createElement("sup",{className:"text-sm"},"1")))),l.createElement("h3",{className:"text-sm lg:text-base font-semibold text-black text-start w-full mb-4 mt-8 lg:mt-0"},"pl-PL"==e?"Źródła:":"References:"),l.createElement("ul",{className:"flex flex-col text-sm lg:text-sm list-decimal list-outside max-w-[740px] mb-4 pr-0 lg:pr-8 pl-4 lg:pl-6 gap-2"},"pl-PL"===e&&l.createElement(l.Fragment,null,l.createElement("li",{className:"pl-2"},'Goette, Julia, et al. "Freezing equals freezing? Performance of two cryoablation devices in concomitant mitral valve repair". The Thoracic and Cardiovascular Surgeon 64.08 (2016): 672-678.'),l.createElement("li",{className:"pl-2"},'Baust, John G., and Andrew A. Gage. "The molecular basis of cryosurgery." BJU international 95.9 (2005).'),l.createElement("li",{className:"pl-2"},"Oparte na danych eksperymentalnych Medinice uzyskanych w trakcie badań przedkl
1inicznych oraz na danych pochodzących z innych dostępnych źródeł.")),"en-US"===e&&l.createElement(l.Fragment,null,l.createElement("li",{className:"pl-2"},'Goette, Julia, et al. "Freezing equals freezing? Performance of two cryoablation devices in concomitant mitral valve repair". The Thoracic and Cardiovascular Surgeon 64.08 (2016): 672-678.'),l.createElement("li",{className:"pl-2"},'Baust, John G., and Andrew A. Gage. "The molecular basis of cryosurgery." BJU international 95.9 (2005).'),l.createElement("li",{className:"pl-2"},"Based on Medinice experimental data during preclinical studies and data from other available sources.")))),l.createElement("div",{className:"lg:w-1/2 flex justify-center items-start ml-0 lg:-ml-10"},"pl-PL"===e?l.createElement(c.S,{src:"../../images/CoolCryofreezingEqfreezingPL.jpg",alt:"Mrożenie CoolCryo vs konkurencja",className:"w-full h-auto max-w-[640px] rounded-md",__imageData:t(81145)}):l.createElement(c.S,{src:"../../images/CoolCryofreezingEqfreezingEN.jpg",alt:"Freezing CoolCryo vs competition",className:"w-full h-auto max-w-[640px] rounded-md",__imageData:t(89362)}))))),l.createElement("section",{className:"w-full flex justify-center items-center pt-10 pb-4 lg:py-20 mt-6 lg:mt-16 mb-0 lg:mb-20 bg-gray-100"},l.createElement(i.H,null,l.createElement("div",{className:"flex flex-col lg:flex-row gap-2 lg:gap-10 pl-0 lg:pl-20"},l.createElement("h3",{className:"flex lg:hidden text-xl lg:text-xl font-bold text-black text-start w-full mb-4 mt-0 lg:mt-0"},"pl-PL"==e?"Bariery i ograniczenia chirurgicznej krioablacji":"Barriers and limitations of surgical cryoablation"),l.createElement("div",{className:"flex flex-col lg:w-1/2 order-2 lg:order-1 pr-0 lg:pr-20"},l.createElement("h3",{className:"hidden lg:flex text-lg lg:text-xl font-bold text-black text-start w-full mb-4 mt-4 lg:mt-0"},"pl-PL"==e?"Bariery i ograniczenia chirurgicznej krioablacji":"Barriers and limitations of surgical cryoablation"),l.createElement("p",{className:"text-base lg:text-xl text-start lg:text-start max-w-[740px] mt-4 lg:mt-0 mb-4 pr-0 lg:pr-8"},"pl-PL"===e&&l.createElement(l.Fragment,null,"Kardiochirurdzy zwracają uwagę na niską ergonomię obecnych systemów oraz wydłużony czas procedury. Ograniczenia to m.in. słaba moc mrożenia, trudność krioablacji grubych tkanek, brak możliwości krioablacji na bijącym sercu, wysoki koszt sprzętu i ograniczony dostęp do czynnika chłodzącego. Podczas operacji zastawki mitralnej 46% chirurgów nie widzi barier, jednak 23% wskazuje na wydłużenie czasu zaklemowania, a 13% na wysokie ryzyko pacjentów jako powody unikania tych rozwiązań."),"en-US"===e&&l.createElement(l.Fragment,null,"Surgeons point to the low usability of current systems and prolonged application time. Key limitations include insufficient freezing power, difficulty cryoablating thick tissues, inability to perform ablation on a beating heart, high equipment costs, and limited access to coolant. During mitral valve surgery, 46% of surgeons report no barriers, but some cite added cross-clamp time (23%) or high patient risk (13%) as reasons preventing wider use of existing systems.")),l.createElement("p",{className:"text-sm lg:text-sm text-start lg:text-start max-w-[740px] mb-4 pr-0 lg:pr-8 italic"},"pl-PL"===e&&l.createElement(l.Fragment,null,"Źródło: Mehaffey, J. Hunter, et al. „Barriers to atrial fibrillation ablation during mitral valve surgery.” The Journal of thoracic and cardiovascular surgery 165.2 (2023): 650-658."),"en-US"===e&&l.createElement(l.Fragment,null,'Source: Mehaffey, J. Hunter, et al. "Barriers to atrial fibrillation ablation during mitral valve surgery." The Journal of thoracic and cardiovascular surgery 165.2 (2023): 650-658.'))),l.createElement("div",{className:"lg:w-1/2 flex justify-center items-start order-1 lg:order-2 rounded-lg overflow-hidden pl-0 lg:-ml-20"},"pl-PL"===e?l.createElement(c.S,{src:"../../images/challenges-in-surgical-ablation-PL.png",alt:"Wyzwania ablacji chirurgicznej",className:"w-full h-auto rounded-lg max-w-[640px]",__imageData:t(4711)}):l.createElement(c.S,{src:"../../images/challenges-in-surgical-ablation-EN.png",alt:"Challenges in surgical ablation",className:"w-full h-auto rounded-lg max-w-[640px]",__imageData:t(33061)}))))),l.createElement("section",{className:"w-full flex justify-center items-center pt-0 pb-0 lg:pb-4 lg:py-0 mt-10 lg:mt-0 mb-0 lg:mb-2"},l.createElement(i.H,null,l.createElement("div",{className:"flex flex-col lg:flex-row gap-2"},l.createElement("h2",{className:"flex lg:hidden text-xl lg:text-3xl font-bold text-black text-start w-full mb-4 mt-0 lg:mt-0"},"pl-PL"==e?"Rozwiązanie":"The Solution"),l.createElement("h3",{className:"flex lg:hidden text-lg lg:text-xl font-bold text-black text-start w-full mb-4 mt-0 lg:mt-0"},"pl-PL"==e?"CoolCryo do krioablacji kardiochirurgicznej":"CoolCryo for surgical ablation"),l.createElement("div",{className:"flex flex-col lg:w-1/2 order-2 lg:order-2 pl-0 lg:pl-4 pr-0 lg:pr-16"},l.createElement("h2",{className:"hidden lg:flex text-xl lg:text-3xl font-bold text-black text-start w-full mb-4 mt-8 lg:mt-0"},"pl-PL"==e?"Rozwiązanie":"The Solution"),l.createElement("h3",{className:"hidden lg:flex text-lg lg:text-xl font-bold text-black text-start w-full mb-4 mt-0 lg:mt-0"},"pl-PL"==e?"CoolCryo do krioablacji kardiochirurgicznej":"CoolCryo for surgical ablation"),l.createElement("p",{className:"text-base lg:text-xl text-start lg:text-start max-w-[740px] mt-4 lg:mt-0 mb-4 pr-0 lg:pr-8"},"pl-PL"===e&&l.createElement(l.Fragment,null,"Co najmniej czterokrotnie szybsza procedura krioablacji chirurgicznej"),"en-US"===e&&l.createElement(l.Fragment,null,"At least four times faster procedure for surgical ablation")),l.createElement("p",{className:"text-base lg:text-xl text-start lg:text-start max-w-[740px] mb-4 lg:mb-4 pr-0 lg:pr-8"},"pl-PL"===e&&l.createElement(l.Fragment,null,"Możliwość krioablacji bardzo grubych tkanek, potencjalnie także komory"),"en-US"===e&&l.createElement(l.Fragment,null,"Possibility of ablating very thick t
1issues, potentially also the ventricle")),l.createElement("p",{className:"text-base lg:text-xl text-start lg:text-start max-w-[740px] mb-4 lg:mb-4 pr-0 lg:pr-8"},"pl-PL"===e&&l.createElement(l.Fragment,null,"Możliwość krioablacji na bijącym sercu"),"en-US"===e&&l.createElement(l.Fragment,null,"Possibility of ablating on a beating heart")),l.createElement("p",{className:"text-base lg:text-xl text-start lg:text-start max-w-[740px] mb-4 lg:mb-4 pr-0 lg:pr-8"},"pl-PL"===e&&l.createElement(l.Fragment,null,"Dostęp przez sternotomię lub metody małoinwazyjne"),"en-US"===e&&l.createElement(l.Fragment,null,"Access through sternotomy or minimally invasive methods"))),l.createElement("div",{className:"lg:w-1/2 flex justify-center items-start order-1 lg:order-1 ml-0 lg:-ml-5"},"pl-PL"===e?l.createElement(c.S,{src:"../../images/CoolCryoPL.jpg",alt:"CoolCryo",className:"w-full h-auto max-w-[520px] rounded-md",__imageData:t(96613)}):l.createElement(c.S,{src:"../../images/CoolCryoEN.jpg",alt:"CoolCryo",className:"w-full h-auto max-w-[520px] rounded-md",__imageData:t(57203)}))))),l.createElement("section",{className:"w-full flex justify-center items-center pt-6 pb-4 lg:pt-20 lg:pb-20 mt-6 lg:mt-12 mb-0 lg:mb-4 bg-gray-100"},l.createElement(i.H,null,l.createElement("div",{className:"flex flex-col lg:flex-row gap-2 lg:gap-10 pl-0 lg:pl-20"},l.createElement("h3",{className:"flex lg:hidden text-lg lg:text-2xl font-bold text-black text-start w-full mb-4 mt-0 lg:mt-0"},"pl-PL"==e?"Opatentowana konstrukcja oraz funkcjonalności":"Patented design and functionalities"),l.createElement("div",{className:"flex flex-col lg:w-1/2 order-2 lg:order-1 pr-0 lg:pr-20"},l.createElement("h3",{className:"hidden lg:flex text-lg lg:text-2xl font-bold text-black text-start w-full mb-4 mt-4 lg:mt-0"},"pl-PL"==e?"Globalna ochrona patentowa":"Global patent protection"),l.createElement("p",{className:"text-base lg:text-xl text-start lg:text-start max-w-[740px] mt-4 lg:mt-0 mb-4 pr-0"},"pl-PL"===e&&l.createElement(l.Fragment,null,"Nasza technologia CoolCryo jest chroniona przez szeroki portfel patentów międzynarodowych, podkreślający nasze zaangażowanie w innowacje. Z patentami przyznanymi na głównych obszarach takich jak Polska, Stany Zjednoczone, Kanada, Chiny, Japonia, Korea Południowa, Indie, EPO i WPO."),"en-US"===e&&l.createElement(l.Fragment,null,"Our CoolCryo technology is protected by a wide portfolio of international patents, highlighting our commitment to innovation. Patents granted in major areas such as Poland, US, Canada, China, Japan, South Korea, India, EPO, and WPO.")),l.createElement("p",{className:"text-base lg:text-xl text-start lg:text-start max-w-[740px] mb-4 pr-0 lg:pr-8"},"pl-PL"===e&&l.createElement(l.Fragment,null,"CoolCryo jest chroniony przez kompleksową i szeroką strategię ochrony własności intelektualnej. Ta szeroka ochrona gwarantuje unikalność, niezawodność i przewagę konkurencyjną naszej technologii na całym świecie."),"en-US"===e&&l.createElement(l.Fragment,null,"CoolCryo is protected by a comprehensive and wide-ranging intellectual property protection strategy. This broad protection ensures uniqueness, reliability, and competitive advantage of our technology worldwide."))),l.createElement("div",{className:"lg:w-1/2 flex justify-center items-start order-1 lg:order-2 rounded-lg overflow-hidden pl-0 lg:-ml-20"},l.createElement(c.S,{src:"../../images/CoolCryopatents.png",alt:"CoolCryo patents",className:"w-full h-auto max-w-[640px] rounded-md",__imageData:t(42547)}))))),l.createElement("section",{className:"w-full flex justify-center items-center mt-0 lg:mt-16 mb-0 lg:mb-0"},l.createElement(i.H,null,l.createElement("div",{className:"w-full flex flex-col-reverse lg:flex-row-reverse gap-2 lg:gap-10"},l.createElement("div",{className:"flex flex-col lg:w-1/2"},l.createElement("h2",{className:"text-xl lg:text-2xl font-bold text-black text-start w-full mb-4 mt-8 lg:mt-0"},"pl-PL"==e?"Zastosowanie CoolCryo w częstoskurczu komorowym":"Potential application of CoolCryo in ventricular tachycardia"),l.createElement("p",{className:"text-base lg:text-lg text-start lg:text-start max-w-[740px]  mb-0 lg:mb-4 pr-0 lg:pr-8"},"pl-PL"===e&&l.createElement(l.Fragment,null,"Niedawny przypadek kliniczny pokazuje obiecujące zastosowanie systemu CoolCryo w leczeniu tachykardii komorowej (VT). Choć farmakoterapia zwykle jest leczeniem pierwszego wyboru w burzy elektrycznej, nawrotowe arytmie mogą wymagać sympatektomii piersiowej lub kardiochirurgicznej ablacji, gdy metody przezcewnikowe zawodzą. U pacjentów, dla których zatrzymanie pracy 
1serca podczas zabiegu jest zbyt ryzykowne, preferuje się ablację na bijącym sercu. Tradycyjne systemy krioablacyjne oparte na argonie lub podtlenku azotu często nie dają wystarczającej mocy. CoolCryo, wykorzystując ciekły azot, pokonuje te ograniczenia, umożliwiając skuteczną krioablację niezależnie od grubości ściany serca czy przepływu krwi.",l.createElement("a",{className:"hidden lg:flex mt-8 lg:mt-8 gap-2 items-center text-blue-600 hover:text-blue-800 transition-all duration-300 ease-in-out transform group underline",href:m},"Klinknij tutaj aby poznać więcej szczegółów",l.createElement(s.A,{className:"w-5 h-5 transition-all duration-300 ease-in-out transform group-hover:translate-x-1"})),l.createElement("a",{className:"lg:hidden flex mt-8 lg:mt-8 gap-2 items-center text-blue-600 hover:text-blue-800 transition-all duration-300 ease-in-out transform group underline",href:g},"Klinknij tutaj aby poznać więcej szczegółów",l.createElement(s.A,{className:"w-5 h-5 transition-all duration-300 ease-in-out transform group-hover:translate-x-1"}))),"en-US"===e&&l.createElement(l.Fragment,null,"A recent use case highlights a promising new application of CoolCryo in the treatment of ventricular tachycardia (VT). While pharmacotherapy is typically the first-line treatment for electrical storm, recurrent ventricular arrhythmias may require thoracic sympathectomy or surgical ablation, particularly when catheter-based techniques are ineffective. In patients who cannot tolerate heart arrest, beating-heart ablation is preferred; however, conventional cryoablation systems using argon or nitrous oxide often lack adequate freezing power. CoolCryo, leveraging liquid nitrogen’s superior freezing capacity, addresses these limitations by enabling effective cryoablation regardless of heart wall thickness or blood flow.",l.createElement("a",{className:"hidden lg:flex mt-8 lg:mt-8 gap-2 items-center text-blue-600 hover:text-blue-800 transition-all duration-300 ease-in-out transform group underline",href:m},"Click here for more details",l.createElement(s.A,{className:"w-5 h-5 transition-all duration-300 ease-in-out transform group-hover:translate-x-1"})),l.createElement("a",{className:"lg:hidden flex mt-8 lg:mt-8 gap-2 items-center text-blue-600 hover:text-blue-800 transition-all duration-300 ease-in-out transform group underline",href:g},"Click here for more details",l.createElement(s.A,{className:"w-5 h-5 transition-all duration-300 ease-in-out transform group-hover:translate-x-1"}))))),l.createElement("div",{className:"lg:w-1/2 flex justify-center items-start order-1 lg:order-2 rounded-lg overflow-hidden pl-0 lg:pl-20 mt-10 lg:mt-0"},l.createElement("iframe",{width:"100%",src:"https://www.youtube.com/embed/BOAWu6qbwJQ",title:"CoolCryo Fakty TVN",frameBorder:"0",allow:"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share",referrerPolicy:"strict-origin-when-cross-origin",allowFullScreen:!0,className:"rounded-xl h-[200px] lg:h-[400px]"}))))),l.createElement("section",{className:"w-full flex justify-start lg:justify-center items-start lg:items-center pt-8 pb-8 lg:pt-10 lg:pb-16 m-0 lg:mt-0 mb-0 lg:mb-0 pl-6 lg:pl-0"},l.createElement(o.Link,{to:"/products",className:"flex w-max justify-start items-start font-bold text-lg py-2 lg:py-2 px-8 rounded-full text-white bg-blue-600 border-2 border-solid border-blue-600 hover:bg-blue-800 hover:border-blue-800 transition-all duration-300 ease-in-out transform hover:scale-105 mt-2"},"pl-PL"==e?"Więcej o naszych innowacjach":"More about our innovations")))}},3702:function(e,a,t){var l=t(96540),r=t(5556),n=t.n(r),o=["color","size","title","className"];function i(){return i=Object.assign?Object.assign.bind():function(e){for(var a=1;a<arguments.length;a++){var t=arguments[a];for(var l in t)({}).hasOwnProperty.call(t,l)&&(e[l]=t[l])}return e},i.apply(null,arguments)}var c=(0,l.forwardRef)((function(e,a){var t=e.color,r=void 0===t?"currentColor":t,n=e.size,c=void 0===n?"1em":n,s=e.title,m=void 0===s?null:s,g=e.className,d=void 0===g?"":g,p=function(e,a){if(null==e)return{};var t,l,r=function(e,a){if(null==e)return{};var t={};for(var l in e)if({}.hasOwnProperty.call(e,l)){if(-1!==a.indexOf(l))continue;t[l]=e[l]}return t}(e,a);if(Object.getOwnPropertySymbols){var n=Object.getOwnPropertySymbols(e);for(l=0;l<n.length;l++)t=n[l],-1===a.indexOf(t)&&{}.propertyIsEnumerable.call(e,t)&&(r[t]=e[t])}return r}(e,o);return l.createElement("svg",i({ref:a,xmlns:"http://www.w3.org/2000/svg",viewBox:"0 0 16 16",width:c,height:c,fill:r,className:["bi","bi-arrow-right",d].filter(
1Boolean).join(" ")},p),m?l.createElement("title",null,m):null,l.createElement("path",{fillRule:"evenodd",d:"M1 8a.5.5 0 0 1 .5-.5h11.793l-3.147-3.146a.5.5 0 0 1 .708-.708l4 4a.5.5 0 0 1 0 .708l-4 4a.5.5 0 0 1-.708-.708L13.293 8.5H1.5A.5.5 0 0 1 1 8"}))}));c.propTypes={color:n().string,size:n().oneOfType([n().string,n().number]),title:n().string,className:n().string},a.A=c},4711:function(e){e.exports=JSON.parse('{"layout":"constrained","backgroundColor":"#c8e8e8","images":{"fallback":{"src":"/static/bd82de3e08cfe16aa47652d57209fd12/c5670/challenges-in-surgical-ablation-PL.png","srcSet":"/static/bd82de3e08cfe16aa47652d57209fd12/13212/challenges-in-surgical-ablation-PL.png 159w,\\n/static/bd82de3e08cfe16aa47652d57209fd12/81cc0/challenges-in-surgical-ablation-PL.png 318w,\\n/static/bd82de3e08cfe16aa47652d57209fd12/c5670/challenges-in-surgical-ablation-PL.png 636w","sizes":"(min-width: 636px) 636px, 100vw"},"sources":[{"srcSet":"/static/bd82de3e08cfe16aa47652d57209fd12/4feb0/challenges-in-surgical-ablation-PL.webp 159w,\\n/static/bd82de3e08cfe16aa47652d57209fd12/60d91/c
1hallenges-in-surgical-ablation-PL.webp 318w,\\n/static/bd82de3e08cfe16aa47652d57209fd12/2cd3f/challenges-in-surgical-ablation-PL.webp 636w","type":"image/webp","sizes":"(min-width: 636px) 636px, 100vw"}]},"width":636,"height":380}')},15627:function(e){e.exports=JSON.parse('{"layout":"constrained","backgroundColor":"#787878","images":{"fallback":{"src":"/static/d965a6ea59cdbe208fd4e9b2f7b56381/5267c/productCoolCryoHeroPhoto.jpg","srcSet":"/static/d965a6ea59cdbe208fd4e9b2f7b56381/fa695/productCoolCryoHeroPhoto.jpg 480w,\\n/static/d965a6ea59cdbe208fd4e9b2f7b56381/a0d3e/productCoolCryoHeroPhoto.jpg 960w,\\n/static/d965a6ea59cdbe208fd4e9b2f7b56381/5267c/productCoolCryoHeroPhoto.jpg 1920w","sizes":"(min-width: 1920px) 1920px, 100vw"},"sources":[{"srcSet":"/static/d965a6ea59cdbe208fd4e9b2f7b56381/95a23/productCoolCryoHeroPhoto.webp 480w,\\n/static/d965a6ea59cdbe208fd4e9b2f7b56381/5bdbe/productCoolCryoHeroPhoto.webp 960w,\\n/static/d965a6ea59cdbe208fd4e9b2f7b56381/9c00f/productCoolCryoHeroPhoto.webp 1920w","type":"image/webp","sizes":"(min-width: 1920px) 1920px, 100vw"}]},"width":1920,"height":1280}')},24663:function(e){e.exports=JSON.parse('{"layout":"constrained","backgroundColor":"#e8e8d8","images":{"fallback":{"src":"/static/afeb1bc7dea09d2a9fc70292cc356d19/50965/cardiacablation.jpg","srcSet":"/static/afeb1bc7dea09d2a9fc70292cc356d19/4828c/cardiacablation.jpg 159w,\\n/static/afeb1bc7dea09d2a9fc70292cc356d19/a54f2/cardiacablation.jpg 318w,\\n/static/afeb1bc7dea09d2a9fc70292cc356d19/50965/cardiacablation.jpg 636w","sizes":"(min-width: 636px) 636px, 100vw"},"sources":[{"srcSet":"/static/afeb1bc7dea09d2a9fc70292cc356d19/4feb0/cardiacablation.webp 159w,\\n/static/afeb1bc7dea09d2a9fc70292cc356d19/60d91/cardiacablation.webp 318w,\\n/static/afeb1bc7dea09d2a9fc70292cc356d19/2cd3f/cardiacablation.webp 636w","type":"image/webp","sizes":"(min-width: 636px) 636px, 100vw"}]},"width":636,"height":380}')},26256:function(e){e.exports=JSON.parse('{"layout":"constrained","backgroundColor":"#c8e8e8","images":{"fallback":{"src":"/static/8479fbbeb173e56a4a6e4ee260d834e2/50965/CoolCryofreezingGraphsPL.jpg","srcSet":"/static/8479fbbeb173e56a4a6e4ee260d834e2/4828c/CoolCryofreezingGraphsPL.jpg 159w,\\n/static/8479fbbeb173e56a4a6e4ee260d834e2/a54f2/CoolCryofreezingGraphsPL.jpg 318w,\\n/static/8479fbbeb173e56a4a6e4ee260d834e2/50965/CoolCryofreezingGraphsPL.jpg 636w","sizes":"(min-width: 636px) 636px, 100vw"},"sources":[{"srcSet":"/static/8479fbbeb173e56a4a6e4ee260d834e2/4feb0/CoolCryofreezingGraphsPL.webp 159w,\\n/static/8479fbbeb173e56a4a6e4ee260d834e2/60d91/CoolCryofreezingGraphsPL.webp 318w,\\n/static/8479fbbeb173e56a4a6e4ee260d834e2/2cd3f/CoolCryofreezingGraphsPL.webp 636w","type":"image/webp","sizes":"(min-width: 636px) 636px, 100vw"}]},"width":636,"height":380}')},33061:function(e){e.exports=JSON.parse('{"layout":"constrained","backgroundColor":"#c8e8e8","images":{"fallback":{"src":"/static/ec633713c452195b7772f95b03710d86/c5670/challenges-in-surgical-ablation-EN.png","srcSet":"/static/ec633713c452195b7772f95b03710d86/13212/challenges-in-surgical-ablation-EN.png 159w,\\n/static/ec633713c452195b7772f95b03710d86/81cc0/challenges-in-surgical-ablation-EN.png 318w,\\n/static/ec633713c452195b7772f95b03710d86/c5670/challenges-in-surgical-ablation-EN.png 636w","sizes":"(min-width: 636px) 636px, 100vw"},"sources":[{"srcSet":"/static/ec633713c452195b7772f95b03710d86/4feb0/challenges-in-surgical-ablation-EN.webp 159w,\\n/static/ec633713c452195b7772f95b03710d86/60d91/challenges-in-surgical-ablation-EN.webp 318w,\\n/static/ec633713c452195b7772f95b03710d86/2cd3f/challenges-in-surgical-ablation-EN.webp 636w","type":"image/webp","sizes":"(min-width: 636px) 636px, 100vw"}]},"width":636,"height":380}')},42547:function(e){e.exports=JSON.parse('{"layout":"constrained","backgroundColor":"#f8f8f8","images":{"fallback":{"src":"/static/cdfa3bdc61169716f5d502ad7a59d307/c5670/CoolCryopatents.png","srcSet":"/static/cdfa3bdc61169716f5d502ad7a59d307/13212/CoolCryopatents.png 159w,\\n/static/cdfa3bdc61169716f5d502ad7a59d307/81cc0/CoolCryopatents.png 318w,\\n/static/cdfa3bdc61169716f5d502ad7a59d307/c5670/CoolCryopatents.png 636w","sizes":"(min-width: 636px) 636px, 100vw"},"sources":[{"srcSet":"/static/cdfa3bdc61169716f5d502ad7a59d307/4feb0/CoolCryopatents.webp 159w,\\n/static/cdfa3bdc61169716f5d502ad7a59d307/60d91/CoolCryopatents.webp 318w,\\n/static/cdfa3bdc61169716f5d502ad7a59d307/2cd3f/CoolCryopatents.webp 636w","type":"image/webp","sizes":"(min-width: 636px) 636px, 100vw"}]},"width":636,"height":380}')},57203:function(e){e.exports=JSON.parse('{"layout":"constrained","backgroundColor":"#c8e8e8","images":{"fallback":{"src":"/static/ffc130f7b62bf90aca02e9aca9ef2841/50965/CoolCryoEN.jpg","srcSet":"/static/ffc130f7b62bf90aca02e9aca9ef2841/4828c/CoolCryoEN.jpg 159w,\\n/static/ffc130f7b62bf90aca02e9aca9ef2841/a54f2/CoolCryoEN.jpg 318w,\\n/static/ffc130f7b62bf90aca02e9aca9ef2841/50965/CoolCryoEN.jpg 636w","sizes":"(min-width: 636px) 636px, 100vw"},"sources":[{"srcSet":"/static/ffc130f7b62bf90aca02e9aca9ef2841/4feb0/CoolCryoEN.webp 159w,\\n/static/ffc130f7b62bf90aca02e9aca9ef2841/60d91/CoolCryoEN.webp 318w,\\n/static/ffc130f7b62bf90aca02e9aca9ef2841/2cd3f/CoolCryoEN.webp 636w","type":"image/webp","sizes":"(min-width: 636px) 636px, 100vw"}]},"width":636,"height":380}')},81145:function(e){e.exports=JSON.parse('{"layout":"constrained","backgroundColor":"#c8e8e8","images":{"fallback":{"src":"/static/b1262fef0ae2bc53b02216ace2ea3c7b/50965/CoolCryofreezingEqfreezingPL.jpg","srcSet":"/static/b1262fef0ae2bc53b02216ace2ea3c7b/4828c/CoolCryofreezingEqfreezingPL.jpg 159w,\\n/static/b1262fef0ae2bc53b02216ace2ea3c7b/a54f2/CoolCryofreezingEqfreezingPL.jpg 318w,\\n/static/b1262fef0ae2bc53b02216ace2ea3c7b/50965/CoolCryofreezingEqfreezingPL.jpg 636w","sizes":"(min-width: 636px) 636px, 100vw"},"sources":[{"srcSet":"/static/b1262fef0ae2bc53b02216ace2ea3c7b/4feb0/CoolCryofreezingEqfreezingPL.webp 159w,\\n/static/b1262fef0ae2bc53b02216ace2ea3c7b/60d91/CoolCryofreezingEqfreezingPL.webp 318w,\\n/static/b1262fef0ae2bc53b02216ace2ea3c7b/2cd3f/CoolCryofreezingEqfreezingPL.webp 636w","type":"image/webp","sizes":"(min-width: 636px) 636px, 100vw"}]},"width":636,"height":380}')},85522:function(e){e.exports=JSON.parse('{"layout":"constrained","backgroundColor":"#c8e8e8","images":{"fallback":{"src":"/static/6e04f9e39221d6150781a07c6a37d708/50965/CoolCryofreezingGraphsEN.jpg","srcSet":"/static/6e04f9e39221d6150781a07c6a37d708/4828c/CoolCryofreezingGraphsEN.jpg 159w,\\n/static/6e04f9e39221d6150781a07c6a37d708/a54f2/CoolCryofreezingGraphsEN.jpg 318w,\\n/static/6e04f9e39221d6150781a07c6a37d708/50965/CoolCryofreezingGraphsEN.jpg 636w","sizes":"(min-width: 636px) 636px, 100vw"},"sources":[{"srcSet":"/static/6e04f9e39221d6150781a07c6a37d708/4feb0/CoolCryofreezingGraphsEN.webp 159w,\\n/static/6e04f9e39221d6150781a07c6a37d708/60d91/CoolCryofreezingGraphsEN.webp 318w,\\n/static/6e04f9e39221d6150781a07c6a37d708/2cd3f/CoolCryofreezingGraphsEN.webp 636w","type":"image/webp","sizes":"(min-width: 636px) 636px, 100vw"}]},"width":636,"height":380}')},88271:function(e){e.exports=JSON.parse('{"layout":"constrained","backgroundColor":"#080808","images":{"fallback":{"src":"/static/9aaeaea8a87919b3cd0dcb91805f7357/50965/atrialfibrillation.jpg","srcSet":"/static/9aaeaea8a87919b3cd0dcb91805f7357/4828c/atrialfibrillation.jpg 159w,\\n/static/9aaeaea8a87919b3cd0dcb91805f7357/a54f2/atrialfibrillation.jpg 318w,\\n/static/9aaeaea8a87919b3cd0dcb91805f7357/50965/atrialfibrillation.jpg 636w","sizes":"(min-width: 636px) 636px, 100vw"},"sources":[{"srcSet":"/static/9aaeaea8a87919b3cd0dcb91805f7357/4feb0/atrialfibrillation.webp 159w,\\n/static/9aaeaea8a87919b3cd0dcb91805f7357/60d91/atrialfibrillation.webp 318w,\\n/static/9aaeaea8a87919b3cd0dcb91805f7357/2cd3f/atrialfibrillation.webp 636w","type":"image/webp","sizes":"(min-width: 636px) 636px, 100vw"}]},"width":636,"height":380}')},89362:function(e){e.exports=JSON.parse('{"layout":"constrained","backgroundColor":"#c8e8e8","images":{"fallback":{"src":"/static/458d2cd88fb2a5946b75ef8fdb1054db/50965/CoolCryofreezingEqfreezingEN.jpg","srcSet":"/static/458d2cd88fb2a5946b75ef8fdb1054db/4828c/CoolCryofreezingEqfreezingEN.jpg 159w,\\n/static/458d2cd88fb2a5946b75ef8fdb1054db/a54f2/CoolCryofreezingEqfreezingEN.jpg 318w,\\n/static/458d2cd88fb2a5946b75ef8fdb1054db/50965/CoolCryofreezingEqfreezingEN.jpg 636w","sizes":"(min-width: 636px) 636px, 100vw"},"sources":[{"srcSet":"/static/458d2cd88fb2a5946b75ef8fdb1054db/4feb0/CoolCryofreezingEqfreezingEN.webp 159w,\\n/static/458d2cd88fb2a5946b75ef8fdb1054db/60d91/CoolCryofreezingEqfreezingEN.webp 318w,\\n/static/458d2cd88fb2a5946b75ef8fdb1054db/2cd3f/CoolCryofreezingEqfreezingEN.webp 636w","type":"image/webp","sizes":"(min-width: 636px) 636px, 100vw"}]},"width":636,"height":380}')},96613:function(e){e.exports=JSON.parse('{"layout":"constrained","backgroundColor":"#c8e8e8","images":{"fallback":{"src":"/static/6f3a7c59af6f66dfe4399de52834e0ef/50965/CoolCryoPL.jpg","srcSet":"/static/6f3a7c59af6f66dfe4399de52834e0ef/4828c/CoolCryoPL.jpg 159w,\\n/static/6f3a7c59af6f66dfe4399de52834e0ef/a54f2/CoolCryoPL.jpg 318w,\\n/static/6f3a7c59af6f66dfe4399de52834e0ef/50965/CoolCryoPL.jpg 636w","sizes":"(min-width: 636px) 636px, 100vw"},"sources":[{"srcSet":"/static/6f3a7c59af6f66dfe4399de52834e0ef/4feb0/CoolCryoPL.webp 159w,\\n/static/6f3a7c59af6f66dfe4399de52834e0ef/60d91/CoolCryoPL.webp 318w,\\n/static/6f3a7c59af6f66dfe4399de52834e0ef/2cd3f/CoolCryoPL.webp 636w","type":"image/webp","sizes":"(min-width: 636px) 636px, 100vw"}]},"width":636,"height":380}')}}]);
2//# sourceMappingURL=component---src-pages-products-coolcryo-tsx-305c37a7bab1d08ffd9f.js.map

Line numbers count LF bytes from the start of the resource, as the search results do. Vendor segments are library code the classifier recognised; they are stored but not indexed. Bytes are shown as Latin1 characters, one per byte.